|
MedChemExpress
i927000 nir178 taminadenant medchem express I927000 Nir178 Taminadenant Medchem Express, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/i927000 nir178 taminadenant medchem express/product/MedChemExpress Average 92 stars, based on 1 article reviews
i927000 nir178 taminadenant medchem express - by Bioz Stars,
2026-03
92/100 stars
|
Buy from Supplier |
|
Novartis
nir178 ![]() Nir178, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/nir178/product/Novartis Average 90 stars, based on 1 article reviews
nir178 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Surface Oncology
nir178 ![]() Nir178, supplied by Surface Oncology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/nir178/product/Surface Oncology Average 90 stars, based on 1 article reviews
nir178 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Corvus Pharmaceuticals
nir 178 ![]() Nir 178, supplied by Corvus Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/nir 178/product/Corvus Pharmaceuticals Average 90 stars, based on 1 article reviews
nir 178 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Frontiers in Immunology
Article Title: Clinical cancer immunotherapy: Current progress and prospects
doi: 10.3389/fimmu.2022.961805
Figure Lengend Snippet: Summary of major marketed and clinically reported small molecule immunotherapy drugs (Up to March 2022).
Article Snippet: A2AR ,
Techniques:
Journal: Frontiers in Immunology
Article Title: Targeting Immunometabolism Mediated by CD73 Pathway in EGFR -Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance
doi: 10.3389/fimmu.2020.01479
Figure Lengend Snippet: Current development status of Adenosine Receptor Antagonists in advanced non-small cell lung cancer.
Article Snippet: NCT03549000 ,
Techniques:
Journal: Frontiers in Immunology
Article Title: Targeting Immunometabolism Mediated by CD73 Pathway in EGFR -Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance
doi: 10.3389/fimmu.2020.01479
Figure Lengend Snippet: Current development status of anti-CD73 strategies in advanced non-small cell lung cancer.
Article Snippet: NCT03549000 ,
Techniques: